Purpose: [ 18 F]-fluorodeoxyglucose-positron emission tomography (FDG-PET) images are usually quantitatively analyzed in "whole-tumor" volumes of interest. Also parameters determined with dynamic PET acquisitions, such as the Patlak glucose metabolic rate (MR glc ) and pharmacokinetic rate constants of 2-tissue compartment modeling are most often derived per lesion. We propose segmentation of tumors to determine tumor heterogeneity, potentially useful for dose-painting in radiotherapy and elucidating mechanisms of FDG uptake.
Introduction
Positron emission tomography (PET) is a molecular imaging technique to quantitatively assess various tissue properties with an appropriate radiotracer such as [ 18 Pharmacokinetic rate constants, and other model-based parameters are usually derived in a VOI, mostly representing the whole tumor. These parameters therefore, correspond to averaged values of tumor glucose metabolic activity. To assess intratumoral heterogeneity, the parameters could be obtained for every individual voxel within the tumor (voxel-wise modeling). The time-activity curves for single voxels, however, are relatively noisy. This prevents accurate determination of tumor parameters using non-linear least squares (NLLS) methods [8] . Moreover, tumor movement (e.g., as a result of breathing) has a relatively large influence in these small volumes as in this case each voxel does not necessarily represent a single volume of tissue.
As a trade-off, less detailed parameters (such as the metabolic rate of glucose (MR glc )) can be used, for which voxel-wise quantification is feasible, since they can be based on linearization methods which are far less sensitive to noise (e.g., using the Patlak method [9]). Another method to overcome high noise levels is to decrease spatial image resolution by reconstruction at smaller matrix sizes.
Post-reconstruction smoothing could also be used to increase signal-to-noise ratios at the cost of spatial resolution.
Similarly, higher signal-to-noise ratios can be obtained by tumor segmentation and taking the mean value in each segment, which could be used to determine tumor regional variation in 2-tissue compartment model rate constants of FDG metabolism (K 1 -k 4 ) and blood volume fraction (V b ).
We applied the latter method and segmented the tumors based on the MR glc images, taking advantage of the higher tumor-to-background ratio as compared to standard uptake images [10] .
Furthermore, we wanted to verify our hypothesis that tumor regions with the highest MR glc are characterized by high FDG extraction and phosphorylation rates.
Patients & methods
Patient population & data acquisition procedure
From an existing database of dynamic FDG-PET scans of oncological patients acquired on a Siemens ECAT EXACT47 (Siemens Healthcare), 41 patients with 104 tumors of different origin ( 
Since pharmacokinetic analysis of dynamic data is sensitive to time-delay (t d , i.e., the difference in time of arrival of the FDG-bolus in the tumor and in the sampled artery), manual time-offset synchronization of C plasma (t) and C tumor (t) of VOI tumor was performed by visually shifting the ascending limbs of both curves until they overlapped.
On images of MR glc , one representative background VOI (VOI BG ) and three tumor VOIs were determined per lesion, defined by increasing levels of background-corrected MR glc (VOI low , VOI medium and VOI high , summing up to VOI tumor ; table 2). The quartile with lowest metabolic rate was not included, as the edges of the metabolic volume may contain non-tumor tissues and the noise levels in this segment is higher due to a lower FDG uptake. We did not attempt any partial-volume correction strategies. VOI BG was defined as an ellipsoidal volume of at least the size of the corresponding tumor and placed in a representative volume of tissue with normal FDG-uptake (e.g., contralateral lung in case of a lung metastasis). 
in a majority of lesions (data on file).
The resulting values for each parameter were classified as being biologically plausible or not.
Values within 3 standard deviations (99.7% confidence interval) of the mean described elsewhere Finally, these parameters were interpreted in view of their reliability (relative standard error) and mutual independence (correlation matrix).
Statistical analysis
(Log e )-normally distributed variables are described by mean and 95%-confidence interval (95%-CI: mean ± 1.96 × standard deviation). Variables not obeying the (log e )-normal distribution are described by median and interquartile range (IQR An example of lesion segmentation with corresponding time-activity concentration curves is displayed in figure 2 . As demonstrated in figure 3 , a clear trend in reduction of K 1 , k 2 , k 3 and increase in V b was observed from VOI high toward VOI low , which was significant for all four investigated parameters. The within-group differences were significant between all segments, except for VOI high versus VOI medium for both K 1 and k 2 . These trends were seen in significantly more than the expected 25% (if divided equally between the 4 possibilities) of the analyzed lesions: 42% (95%-CI: 33 -52%) 
Discussion
When comparing tumor regions with stepwise decreasing MR glc , there is decreasing phosphorylation rate (k 3 ) but increasing fractional blood volume (V b ). This cannot be explained by mutual dependence of these variables in the fitting process, since the fit-correlation was low. We could not find a significant correlation between whole-tumor V b and k 3 between lesions. Glucose phosphorylation rate therefore is not correlated with lesion blood volume fraction. Miles and Williams Tumor hypoxia is disadvantageous property for several cancer treatments including radiation therapy [23] . Numerous methods to detect or visualize hypoxia in vivo are available which include hypoxia specific PET tracers such as FMISO. Some suggest to employ FDG-PET for dose painting because of the disadvantages of hypoxia tracers, e.g., a low tumor to background ratio, low reproducibility, and slow clearance of these tracers in non-hypoxic regions [24] . Although FDG is certainly not a tracer specific for hypoxia, there is a correlation between FDG uptake and hypoxia in tumors [25] . More details about the metabolism of FDG can be obtained using dynamic PET. We have shown an inverse relation between V b and k 3 , which might be indicative for a poorer oxygenation in the metabolic centre of the tumor, because of increased demand of oxygen and nutrients (higher phosphorylation), but decreased delivery (lower volume fraction of blood). Continuous uptake of FDG, despite a poor vasculature, is a sign of adaptation of the tumor to the hypoxic conditions. The intratumoral metabolic heterogeneity suggests differences in the tumor microenvironment (including distribution of hypoxia), which might have an impact on radiation treatment planning.
We do not believe that the high number of lesions with outlying parameters influenced our conclusions as we saw similar results in the subgroup of lesions in which all parameter values were considered biologically plausible.
A potentially disturbing factor is image blurring, both due to partial-volume-effects and (periodic) movements such as breathing. However, the subgroups of lesions least influenced by both causes of blurring (i.e., tumor volumes at least 5 times the scanners spatial resolution) showed similar results to the whole-group analysis, which demonstrates the limited role of these perturbing factors on our results.
Conclusion
Regions of tumors with highest MR glc are characterized by high cellular uptake and phosphorylation rate constants with relatively low blood volume fractions. In regions with less metabolic activity, the blood volume fraction gradually increases and cellular uptake, washout and phosphorylation rate constants decrease. These results are not due to covariance of the regression coefficients and might be relevant for understanding tumor biology and for dose-painting in radiotherapy. Tables, page 4 
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